doxapram has been researched along with Snoring in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Snoring: Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sleep apnea syndromes have been recognized clinically in the United States only within the past ten years." | 2.36 | Sleep apnea syndromes. ( Chaudhary, BA; Speir, WA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, BA | 1 |
| Speir, WA | 1 |
1 review available for doxapram and Snoring
| Article | Year |
|---|---|
Sleep apnea syndromes.
Topics: Body Weight; Doxapram; Humans; Oxygen Inhalation Therapy; Physical Examination; Progesterone; Sleep | 1982 |